This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignee: Leland Stanford Junior University. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2024
Title: Kelly Marie McKenna: A Pioneering Inventor in Cancer Treatment Technologies
Introduction
Kelly Marie McKenna is an innovative inventor based in Palo Alto, California, known for her critical contributions to the field of cancer treatment. With three patents to her name, McKenna has made significant strides in targeted therapies that enhance the treatment outcomes for cancer patients.
Latest Patents
Her most recent patents focus on groundbreaking methods for treating cancer through dual targeting of CD47 and EGFR. These methods involve a regimen designed to deplete cancer cells effectively by utilizing a combination of agents. The first agent blockades CD47 activity, while the second is an antibody that binds specifically to EGFR. Notably, her innovations target cancer cells that may possess mutated forms of KRAS, NRAS, or BRAF. The approach she has developed enhances the level of cell depletion when compared to treatments using a single agent, exhibiting a synergistic effect that can significantly improve therapeutic outcomes.
Career Highlights
Kelly McKenna is associated with the Leland Stanford Junior University, where she collaborates on transformative research initiatives in cancer biology and therapy. Her focus on innovative treatment methods has positioned her as a leading figure in the ongoing efforts to develop more effective cancer treatments.
Collaborations
Throughout her career, McKenna has worked alongside several distinguished colleagues, including Irving L. Weissman and Doris Po Yi Ho. Their combined expertise fosters a rich collaborative environment that drives the advancement of cancer research and innovative treatment strategies.
Conclusion
In conclusion, Kelly Marie McKenna exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her patents and ongoing research initiatives are paving the way for new therapeutic options that may alter the course of treatment for many patients facing cancer, highlighting the importance of inventive thinking in addressing pressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile